Security key
004225108
ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)
CUSIP: 004225108
Q1 2015 13F Holders as of 31 Mar 2015
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 170,504,990
- Total 13F shares
- 97,313,733
- Share change
- +1,018,129
- Total reported value
- $3,171,615,843
- Put/Call ratio
- 72%
- Price per share
- $32.59
- Number of holders
- 193
- Value change
- +$38,284,508
- Number of buys
- 99
- Number of sells
- 85
Report period
Q1 2015
Institutions
193
Top holders
10
ACAD full security history
Newer quarter: Q2 2015
Previous quarter: Q4 2014
ACADIA PHARMACEUTICALS INC SEC filings
ACADIA PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 004225108
Recent filing periods:
Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP |
13F
|
Company |
12%
|
20,481,442
|
$650,286,000 | — | 31 Dec 2014 | |
| FMR LLC |
13F
|
Company |
8.8%
|
14,965,545
|
$475,156,000 | — | 31 Dec 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3.7%
|
6,240,798
|
$198,145,000 | — | 31 Dec 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
4,882,201
|
$155,011,000 | — | 31 Dec 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.9%
|
3,191,785
|
$101,339,000 | — | 31 Dec 2014 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
1.7%
|
2,956,266
|
$93,861,000 | — | 31 Dec 2014 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.7%
|
2,874,016
|
$91,250,000 | — | 31 Dec 2014 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
1.6%
|
2,653,382
|
$84,245,000 | — | 31 Dec 2014 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.4%
|
2,350,749
|
$74,637,000 | — | 31 Dec 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.2%
|
2,060,610
|
$65,424,000 | — | 31 Dec 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
1,911,140
|
$60,678,000 | — | 31 Dec 2014 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
1,789,626
|
$56,824,000 | — | 31 Dec 2014 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.98%
|
1,674,562
|
$53,167,000 | — | 31 Dec 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.88%
|
1,494,897
|
$47,463,000 | — | 31 Dec 2014 | |
| Capital World Investors |
13F
|
Company |
0.79%
|
1,343,000
|
$42,640,000 | — | 31 Dec 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.78%
|
1,333,500
|
$42,339,000 | — | 31 Dec 2014 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.76%
|
1,291,770
|
$41,014,000 | — | 31 Dec 2014 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.76%
|
1,289,609
|
$40,945,000 | — | 31 Dec 2014 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.64%
|
1,093,281
|
$34,712,000 | — | 31 Dec 2014 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.6%
|
1,018,600
|
$32,341,000 | — | 31 Dec 2014 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.6%
|
1,015,801
|
$32,252,000 | — | 31 Dec 2014 | |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.59%
|
1,002,114
|
$31,817,000 | — | 31 Dec 2014 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.53%
|
896,555
|
$28,465,000 | — | 31 Dec 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.52%
|
881,585
|
$27,990,000 | — | 31 Dec 2014 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
864,437
|
$27,446,000 | — | 31 Dec 2014 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.4%
|
679,631
|
$21,578,000 | — | 31 Dec 2014 | |
| NORGES BANK |
13F
|
Company |
0.39%
|
669,391
|
$21,253,000 | — | 31 Dec 2014 | |
| HARVEY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.34%
|
577,700
|
$18,341,000 | — | 31 Dec 2014 | |
| MORGAN STANLEY |
13F
|
Company |
0.3%
|
512,335
|
$16,266,000 | — | 31 Dec 2014 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.29%
|
497,530
|
$15,797,000 | — | 31 Dec 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
489,316
|
$15,535,000 | — | 31 Dec 2014 | |
| WEATHERBIE CAPITAL, LLC |
13F
|
Company |
0.28%
|
470,805
|
$14,948,000 | — | 31 Dec 2014 | |
| Invesco Ltd. |
13F
|
Company |
0.27%
|
457,530
|
$14,527,000 | — | 31 Dec 2014 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
450,045
|
$14,289,000 | — | 31 Dec 2014 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.25%
|
431,345
|
$13,695,000 | — | 31 Dec 2014 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.25%
|
423,200
|
$13,437,000 | — | 31 Dec 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
359,803
|
$11,422,000 | — | 31 Dec 2014 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.21%
|
354,278
|
$11,248,000 | — | 31 Dec 2014 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.19%
|
319,521
|
$10,144,000 | — | 31 Dec 2014 | |
| Allen Investment Management, LLC |
13F
|
Company |
0.18%
|
300,000
|
$9,525,000 | — | 31 Dec 2014 | |
| Bodri Capital Management, LLC |
13F
|
Company |
0.18%
|
300,000
|
$9,525,000 | — | 31 Dec 2014 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.17%
|
293,565
|
$9,321,000 | — | 31 Dec 2014 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.17%
|
281,626
|
$8,942,000 | — | 31 Dec 2014 | |
| Cupps Capital Management, LLC |
13F
|
Company |
0.16%
|
272,350
|
$8,647,000 | — | 31 Dec 2014 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.16%
|
266,604
|
$8,465,000 | — | 31 Dec 2014 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.13%
|
222,812
|
$7,074,000 | — | 31 Dec 2014 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
221,394
|
$7,030,000 | — | 31 Dec 2014 | |
| Asset Management One Co., Ltd. |
13F
|
Company |
0.13%
|
219,197
|
$7,005,000 | — | 31 Dec 2014 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.13%
|
216,723
|
$6,881,000 | — | 31 Dec 2014 | |
| MANAGED ACCOUNT ADVISORS LLC |
13F
|
Company |
0.13%
|
215,000
|
$6,827,000 | — | 31 Dec 2014 |
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q1 2015
As of 31 Mar 2015,
ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,313,733 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, Capital World Investors, BlackRock Fund Advisors, JANUS CAPITAL MANAGEMENT LLC, WADDELL & REED FINANCIAL INC, and JENNISON ASSOCIATES LLC.
This page lists
193
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
182
Q1 2015 holders
193
Holder diff
11
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 Value $ | Q1 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.